QC
RPRX icon

Quent Capital’s Royalty Pharma RPRX Stock Holding History

Quent Capital’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92K Buy
52
+48
+1,200% +$2.5K ﹤0.01% 1428
2026
Q1 		$192 Buy
+4
New +$175 ﹤0.01% 1504
2025
Q2 		– Sell
-65
Closed -$2.02K – 1051
2025
Q1 		$2.02K Hold
65
– – ﹤0.01% 1139
2024
Q4 		$1.66K Sell
65
-123
-65% -$3.26K ﹤0.01% 1192
2024
Q3 		$5.32K Hold
188
– – ﹤0.01% 1093
2024
Q2 		$4.96K Buy
188
+123
+189% +$3.41K ﹤0.01% 1090
2024
Q1 		$1.97K Hold
65
– – ﹤0.01% 1233
2023
Q4 		$1.83K Buy
+65
New +$1.79K ﹤0.01% 1212

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quent Capital's RPRX Position: Q2 2026 in Review

Quent Capital increased its Royalty Pharma (RPRX) stake by 1,200% in Q2 2026, buying an estimated $2.5K and bringing the position to 52 shares worth $2.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1428.

Quent Capital first reported a position in RPRX in Q4 2023 and has held it in 8 quarters since. The position peaked at $5.32K in Q3 2024. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Quent Capital held 52 shares of Royalty Pharma worth $2.92K as of Q2 2026.
  • Quent Capital bought 48 Royalty Pharma shares in Q2 2026, an estimated $2.5K.
  • Royalty Pharma made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1428 holding.
  • Quent Capital first reported a position in Royalty Pharma in Q4 2023 and has held it in 8 quarters since.
  • Quent Capital's Royalty Pharma position peaked at $5.32K in Q3 2024.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.